ScholarIQanswers from OpenAlex

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer

PaperCitations, authors & open-access status

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer have?

ScholarIQcitation count

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer has 155 citations in the OpenAlex counts ScholarIQ stores.

When was TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer published?

ScholarIQyear

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer has 2014 year in the ScholarIQ index.

What is the open-access status of TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer?

ScholarIQoa status

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer has bronze oa status in the ScholarIQ index.

What is the DOI of TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer?

ScholarIQdoi

The DOI for TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer is on the source record.

What is the PMID of TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer?

ScholarIQpmid

The PMID for TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer is on the source record.

What is the OpenAlex record for TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer?

ScholarIQopenalex

The OpenAlex for TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial